Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis

NeuroToxicology

Volumn 28, Issue 3, 2007, Pages 450-456

  Alimonti, Alessandro ^a   Ristori, Giovanni ^b   Giubilei, Franco ^b   Stazi, Maria Antonia ^a   Pino, Anna ^a   Visconti, Andrea ^b   Brescianini, Sonia ^a   Monti, Micaela Sepe ^b   Forte, Giovanni ^a   Stanzione, Paolo ^c   Bocca, Beatrice ^a   Bomboi, Giuseppe ^b   D'Ippolito, Cristina ^a   Annibali, Viviana ^b   Salvetti, Marco ^b   Sancesario, Giuseppe ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Alzheimer's disease; Chemical elements; Forward discriminant analysis; Multiple sclerosis; Parkinson disease; Serum oxidative status

Indexed keywords

CALCIUM; ELEMENT; IRON; SILICON; TIN; VANADIUM; ZINC; ZIRCONIUM;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; ELEMENTS; FEMALE; FREE RADICALS; HUMANS; HYDROGEN PEROXIDE; MALE; METALS; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; PARKINSON DISEASE;

EID: 34249669195     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2006.12.001     Document Type: Article

References (37)

1. Alimonti A., Bocca B., Mannella E., Petrucci F., Zennaro F., Cotichini R., et al. Assessment of reference values for selected elements in a healthy urban population. Ann Ist Super Sanita 41 2 (2005) 181-187
2. Bates M.N., Fawcett J., Garrett N., Cutress T., and Kjellstrom T. Health effects of dental amalgam exposure: a retrospective cohort study. Int J Epidemiol 33 4 (2004) 894-902
3. Bocca B., Forte G., Petrucci F., Pino A., Marchione F., Bomboi G., et al. Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita 41 2 (2005) 197-203
4. Bonferroni C.E. Teoria statistica delle classi e calcolo delle probabilità. Ist Super Scienze Econom Comm Firenze 8 (1936) 3-62
5. Burdette S.C., and Lippard S.J. Meeting of the minds: metalloneurochemistry. Proc Natl Acad Sci USA 100 7 (2003) 3605-3610
6. Bush A.I. Metals and neuroscience. Curr Opin Chem Biol 4 2 (2000) 184-191
7. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci 26 4 (2003) 207-214
8. Corrigan F.M., Van Rhijn A.G., Ijomah G., McIntyre F., Skinner E.R., Horrobin D.F., et al. Tin and fatty acids in dementia. Prostaglandins Leukot Essent Fatty Acids 43 4 (1991) 229-238
9. Daniel S.E., and Lees A.J. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39 (1993) 165-172
10. Doraiswamy P.M., and Finefrock A.E. Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 3 7 (2004) 431-434
11. Forte G., Alimonti A., Pino A., Stanzione P., Brescianini S., Brusa L., et al. Metals and oxidative stress in patients with Parkinson's disease. Ann Ist Super Sanita 41 2 (2005) 189-195
12. Forte G., Bocca B., Senofonte O., Petrucci F., Brusa L., Stanzione P., et al. Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. J Neural Transm 111 8 (2004) 1031-1040
13. Good P.F., Olanow C.W., and Perl D.P. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 593 2 (1992) 343-346
14. Gorell J.M., Peterson E.L., Rybicki B.A., and Johnson C.C. Multiple risk factors for Parkinson's disease. J Neurol Sci 217 2 (2004) 169-174
15. Hegde M.L., Shanmugavelu P., Vengamma B., Rao T.S., Menon R.B., Rao R.V., et al. Serum trace element levels and the complexity of inter-element relations in patients with Parkinson's disease. J Trace Elem Med Biol 18 2 (2004) 163-171
16. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 5 (1967) 427-442
17. Johnson S. The possible role of gradual accumulation of copper, cadmium, lead and iron and gradual depletion of zinc, magnesium, selenium, vitamins B2, B6, D, and E and essential fatty acids in multiple sclerosis. Med Hypotheses 55 3 (2000) 239-241
18. Logroscino G., Marder K., Graziano J., Freyer G., Slavkovich V., LoIacono N., et al. Altered systemic iron metabolism in Parkinson's disease. Neurology 49 3 (1997) 714-717
19. Martin R., and Leppert D. A plea for "omics" research in complex diseases such as multiple sclerosis-a change of mind is needed. J Neurol Sci 222 1-2 (2004) 3-5
20. 2+ influx in T lymphocytes from patients with multiple sclerosis. Proc Natl Acad Sci USA 91 11 (1994) 4825-4829
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
22. Morrison D.F. Multivariate statistical methods (1976), Mc Graw-Hill, Tokyo
23. Olanow C.W., and Arendash G.W. Metals and free radicals in neurodegeneration. Curr Opin Neurol 7 6 (1994) 548-558
24. Opazo C., Huang X., Cherny R.A., Moir R.D., Roher A.E., White A.R., et al. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J Biol Chem 277 43 (2002) 40302-40308
25. Ozcankaya R., and Delibas N. Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. Croat Med J 43 1 (2002) 28-32
26. Pare S., Barr S.I., and Ross S.E. Effect of daytime protein restriction on nutrient intakes of free-living Parkinson's disease patients. Am J Clin Nutr 55 3 (1992) 701-707
27. Pino A., Brescianini S., D'Ippolito C., Fagnani C., Alimonti A., and Stazi M.A. Discriminant analysis to study trace elements in biomonitoring: an application on neurodegenerative diseases. Ann Ist Super Sanita 41 2 (2005) 223-228
28. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58 6 (2005) 840-846
29. Sayre L.M., Moreira P.I., Smith M.A., and Perry G. Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita 41 2 (2005) 143-164
30. Sfagos C., Makis A.C., Chaidos A., Hatzimichael E.C., Dalamaga A., Kosma K., et al. Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients. Mult Scler 11 3 (2005) 272-275
31. Squitti R., Lupoi D., Pasqualetti P., Dal Forno G., Vernieri F., Chiovenda P., et al. Elevation of serum copper levels in Alzheimer's disease. Neurology 59 8 (2002) 1153-1161
32. Squitti R., Pasqualetti P., Cassetta E., Dal Forno G., Cesaretti S., Pedace F., et al. Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia. Neurology 60 12 (2003) 2013-2014
33. Squitti R., Pasqualetti P., Dal Forno G., Moffa F., Cassetta E., Lupoi D., et al. Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 64 6 (2005) 1040-1046
34. Stys P.K. General mechanisms of axonal damage and its prevention. J Neurol Sci 233 1-2 (2005) 3-13
35. Szpunar J. Advances in analytical methodology for bioinorganic speciation analysis: metallomics, metalloproteomics and heteroatom-tagged proteomics and metabolomics. Analyst 130 4 (2005) 442-465
36. Tudor R., Zalewski P.D., and Ratnaike R.N. Zinc in health and chronic disease. J Nutr Health Aging 9 1 (2005) 45-51
37. Zecca L., Youdim M.B., Riederer P., Connor J.R., and Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5 11 (2004) 863-873